Home » Trials » SLCTR/2013/003


Effects of early versus delayed umbilical cord clamping during ante-partum lower segment caesarean section on placental delivery and post operative blood loss : A Randomized Controlled Trial.

-

SLCTR Registration Number

SLCTR/2013/003


Date of Registration

20 Jan 2013

The date of last modification

Mar 03, 2019


View original TRDS


Trial Status



Application Summary


Scientific Title of Trial

Effects of early versus delayed umbilical cord clamping during ante-partum lower segment caesarean section on placental delivery and post operative blood loss : A Randomized Controlled Trial.


Public Title of Trial

Effects of early versus delayed umbilical cord clamping during ante-partum lower segment caesarean section on placental delivery and post operative blood loss : A Randomized Controlled Trial.


Disease or Health Condition(s) Studied

Caesarean delivery techniques


Scientific Acronym

None


Public Acronym

None


Brief title

Delayed cord clamping


Universal Trial Number

None


Any other number(s) assigned to the trial and issuing authority

None


Trial Details


What is the research question being addressed?

Is delayed umbilical cord clamping during ante-partum lower segment caesarean section associated with increased time interval for placental delivery and increased post operative blood loss?


Type of study

Interventional


Study design

Allocation

Randomized controlled trial


Masking

Single blinded


Control

Active


Assignment

Parallel


Purpose

Prevention


Study Phase

Not Available


Intervention(s) planned

Consenting women who fill the inclusion criteria will be randomized into 3 arms using computer generated random numbers. Caesarean sections will be carried out by the principle investigator and the same routine operative techniques will be used. The umbilical cord of the baby will be clamped as soon as possible and in <15 seconds (Group 1) or between 60 – 75 seconds (Group 2) or between 120 – 135 seconds (Group 3) The Anaesthetist will be blinded and he will carry out a separate visual estimation of blood loss using soaked gauze towels & contents of sucker bottle (blood & liquor with correction for liquor) The Principal Investigator not blinded and direct measurement, gravimetric method & calculation based on pre & post CS Hb will be carried out by him.


Inclusion criteria

• Women undergoing elective LSCS • POG between 37-42 weeks • Intact membranes • Healthy foetal parameters


Exclusion criteria

Rh negative mothers • High risk of PPH : multiple pregnancies, fetal macrosomia (estimated fetal weight >3.5 kg), polyhydramnios (AFI >25), severe hypertension in pregnancy (BP>160/110mmHg), placenta previa abruptio placentae • Pre-labour rupture of membranes • Failed inductions



Primary outcome(s)

1.

Time interval from delivery of the baby to the delivery of the placenta

[

During LSCS

]
2.

Mean blood loss in ml

[

During LSCS

]
3.

Maternal Hb & PCV

[

At baseline and post-operatively after 48-60 hours

]

Secondary outcome(s)

1.

Maternal complications: i. Blood transfusion ii. Manual removal of placentae iii. Need of additional uterotonics

[

Intra and post operatively until discharge

]
2.

Neonatal complications: i. Neonatal jaundice requiring phototherapy ii. 5 minutes APGAR <7 iii. Respiratory Distress Syndrome. iv. Needing admission to Special Care Baby Unit

[

From time of delivery up to 72 hours

]

Target number/sample size

150 (50 per arm)


Countries of recruitment

Sri Lanka


Anticipated start date

2013-01-21


Anticipated end date

2013-04-30


Date of first enrollment

2013-01-21


Date of study completion


Recruitment status

Complete: follow up complete


Funding source

None


Regulatory approvals



State of Ethics Review Approval


Status

Approved


Date of Approval

2012-11-22


Approval number

Not Available


Details of Ethics Review Committee

Name: Ethics Review Committee, Faculty of Medicine, University of Ruhuna
Institutional Address:PO Box 70, Labuduwa Rd, Galle, Sri Lanka
Telephone:+94-91-2234801/803 (Extension: 161)
Email: ethics@med.ruh.ac.lk

Contact & Sponsor Information


Contact person for Scientific Queries/Principal Investigator

Dr. M.R Withanathanthrige
Registrar in Obstetrics and Gynaecology
Teaching Hospital, Mahamodara, Sri Lanka

077 2246010

manojwithanathantrige@yahoo.com

Contact Person for Public Queries

Professor Malik Goonewardene
Senior Professor and Head
Department Department of Obstetrics and Gynaecology Faculty of Medicine, PO Box 70, Galle
091-2246878, 091-2234121


malikg@eureka.lk


Primary study sponsor/organization

Department of Obstetrics & Gynaecology,Faculty of Medicine, University of Ruhuna.

P.O.Box 70, Galle, Sri Lanka



Secondary study sponsor (If any)

None





Trial Completion details


Do the investigators plan to share identified individual clinical trial participant-level data (IPD)?


IPD sharing plan description


Study protocol available


Protocol version and date

Not Available


Protocol URL

Not Available


Results summary available

No


Date of posting results


Date of study completion


Final sample size


Date of first publication


Link to results


Brief summary of results